44% Of Adults Taking GLP-1 Medications Report Reduced Alcohol Consumption

Among U.S. adults who used glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications for weight loss or chronic conditions and drank alcohol when they started treatment, 44.2% reported reducing their alcohol consumption during the first three months of treatment. Those who screened positive for potentially unhealthy alcohol use were 2.3 times more likely to report reducing their consumption. The findings were based on self-reported drinking behavior and do not establish that the medications caused the reductions.

Among 242 GLP-1 RA users who reported drinking alcohol when they started treatment, 44.2% reported drinking . . .